ALLUCENT (UK) LIMITED
Get an alert when ALLUCENT (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-27 (in 6mo)
Last made up 2025-11-13
Watchouts
None on the register
Cash
£841K
+40.7% vs 2023
Net assets
£2M
-50.5% vs 2023
Employees
81
+44.6% vs 2023
Profit before tax
-£2M
+19.3% vs 2023
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £15,877,737 | £15,324,563 | |
| Operating profit | -£2,218,075 | -£1,793,860 | |
| Profit before tax | -£2,221,585 | -£1,793,862 | |
| Net profit | -£2,224,796 | -£1,796,957 | |
| Cash | £597,934 | £841,448 | |
| Total assets less current liabilities | £3,560,530 | £1,763,573 | |
| Net assets | £3,560,530 | £1,763,573 | |
| Equity | £3,560,530 | £1,763,573 | |
| Average employees | 56 | 81 | |
| Wages | £5,486,339 | £6,220,341 | |
| Directors' remuneration | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-3.5%
£15,877,737 £15,324,563
-
Cash
+40.7%
£597,934 £841,448
-
Net assets
-50.5%
£3,560,530 £1,763,573
-
Employees
+44.6%
56 81
-
Operating profit
+19.1%
-£2,218,075 -£1,793,860
-
Profit before tax
+19.3%
-£2,221,585 -£1,793,862
-
Wages
+13.4%
£5,486,339 £6,220,341
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | -14.0% | -11.7% | |
| Net margin | -14.0% | -11.7% | |
| Return on capital employed | -62.3% | -101.7% | |
| Current ratio | 1.19x | 1.06x | |
| Interest cover | -631.93x | -896930.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- ALLUCENT (UK) LIMITED 2023-02-20 → present
- PHARM-OLAM INTERNATIONAL (UK) LIMITED 1995-11-14 → 2023-02-20
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- UHY Hacker Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements of the company have been prepared on a going concern basis, which the directors believe to be appropriate. New Pharm-Olam Holdings LLC, the ultimate parent company, has confirmed its intention to support the company, as required, to ensure that the company can meet its obligations for a period of at least one year from the date of issuance of these financial statements.”
Group structure
- ALLUCENT (UK) LIMITED · parent
- Allucent (Belgium) BVBA 99%
- Allucent (IT) S.R.L. 100%
- Allucent (FR) SAS 100%
- Allucent (ES) SL 100%
- Allucent (PL) (Polska) Sp z.o.o. 100%
- Allucent DOO Beograd 100%
- Allucent(CZ) s.r.o. 100%
- Allucent (India) Pvt. Ltd 100%
- Allucent Klinik Arastirma Ve Deney Ticaret Limited Sirketi 100%
- Allucent (HU) Kft 100%
- Allucent(HR) d.o.o. 100%
- Allucent Research Israel Ltd 100%
- Pharm-Olam (Bulgaria) EOOD 100%
Significant events
- “On 1 January 2024, Allucent Group (UK) Limited transferred its entire shareholding in Pharm-Olam International Deutchland GmbH to Allucent (DE) GmbH. The transfer was executed as part of a group reorganisation and was completed by way of a share-for-share exchange.”
- “During 2024 results have continued to be impacted by increase on interest rates and slow down on customer decision to roll out new clinical trials during the current year plus cancellations / delays on new trials. Following the market conditions, revenue has decreased, and the company has seen a pause new business wins, which will drive the revenue in 2025 and beyond.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BRAND, Howard | Secretary | 2025-11-12 | — | — |
| BRAND, Howard | Director | 2025-01-08 | Apr 1972 | American |
| STAFFORD, Paula Brown | Director | 2025-01-08 | May 1964 | American |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BRENNAN, Chris | Secretary | 2021-12-16 | 2025-11-12 |
| MUNK, Susan | Secretary | 1995-11-14 | 2017-11-20 |
| AGROSKIN, Daniel | Director | 2021-12-16 | 2025-01-08 |
| BARRY, John David | Director | 2017-11-20 | 2020-03-27 |
| BRENNAN, Christopher | Director | 2025-01-08 | 2025-11-12 |
| DAVIE, Robert James | Director | 2020-03-27 | 2021-12-16 |
| GASSEN, Natalie Kay | Director | 2017-11-20 | 2022-08-01 |
| GOLDBERG, Mark Alan | Director | 2021-12-16 | 2025-01-08 |
| GRANGE, David Lawrence | Director | 2017-11-20 | 2020-03-27 |
| KHAN, Yamin | Director | 2017-11-20 | 2019-07-26 |
| MUNK, Susan | Director | 1997-02-12 | 2017-11-20 |
| MUNK, Zev Moshe | Director | 1995-11-14 | 2017-11-20 |
| NATORFF, Benona Lillian, Dr | Director | 1997-02-12 | 2000-10-23 |
| SHIMOTA, Richard William | Director | 2021-12-16 | 2025-01-08 |
| STROTHMAN, Peter Maurice | Director | 2021-12-16 | 2025-01-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr Zev Moshe Munk | Individual | Significant influence | 2016-04-06 | Ceased 2020-06-19 |
| Allucent (Uk) Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 115 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-02-20 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-09 | AA | accounts | Accounts with accounts type full | |
| 2025-11-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-13 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-13 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-11-13 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-01-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-06 | AA | accounts | Accounts with accounts type medium | |
| 2024-01-06 | AA | accounts | Accounts with accounts type medium | |
| 2023-12-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-07 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-12-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-02-20 | CERTNM | change-of-name | Certificate change of name company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.